Terms: = Colorectal cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884
238 results:
1. MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaboration.
Chen J; Duan S; Wang Y; Ling Y; Hou X; Zhang S; Liu X; Long X; Lan J; Zhou M; Xu H; Zheng H; Zhou J
Nat Commun; 2024 Jun; 15(1):4969. PubMed ID: 38862489
[TBL] [Abstract] [Full Text] [Related]
2. Novel tropane analogues as hsp90 inhibitors targeting colon cancer: Synthesis, biological estimation, and molecular docking study.
Almehmadi SJ; Sabour R; Kassem AF; Abbas EMH; Alsaedi AMR; Farghaly TA
Bioorg Chem; 2024 Sep; 150():107497. PubMed ID: 38852311
[TBL] [Abstract] [Full Text] [Related]
3. Exploring active ingredients and mechanisms of Coptidis Rhizoma-ginger against colon cancer using network pharmacology and molecular docking.
Zeng T; Ling C; Liang Y
Technol Health Care; 2024; 32(S1):523-542. PubMed ID: 38759074
[TBL] [Abstract] [Full Text] [Related]
4. Targeted delivery of hsp90 inhibitors for efficient therapy of CD44-positive acute myeloid leukemia and solid tumor-colon cancer.
Jia L; Yang H; Liu Y; Zhou Y; Li G; Zhou Q; Xu Y; Huang Z; Ye F; Ye J; Liu A; Ji C
J Nanobiotechnology; 2024 Apr; 22(1):198. PubMed ID: 38649957
[TBL] [Abstract] [Full Text] [Related]
5. Discovery of a novel small-molecule activator of SIRT3 that inhibits cell proliferation and migration by apoptosis and autophagy-dependent cell death pathways in colorectal cancer.
Mou Y; Chen Y; Fan Z; Ye L; Hu B; Han B; Wang G
Bioorg Chem; 2024 May; 146():107327. PubMed ID: 38579616
[TBL] [Abstract] [Full Text] [Related]
6. Prediction of potential mechanisms of rhubarb therapy for colorectal cancer based on network pharmacological analysis and molecular docking.
Yang F; Li X; Zhang Y; Ren Y; Zhang J; Xiao K
Medicine (Baltimore); 2024 Mar; 103(12):e37477. PubMed ID: 38518016
[TBL] [Abstract] [Full Text] [Related]
7. JD-02, a novel hsp90 inhibitor, induces ROS/SRC axis-dependent cytoprotective autophagy in colorectal cancer cells.
Lan N; Su Y; Zeng Q; Zhou P; Hu Y; Zhang Z; Wang Y; Liu K
Mol Carcinog; 2024 Jun; 63(6):1038-1050. PubMed ID: 38411361
[TBL] [Abstract] [Full Text] [Related]
8. Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer.
Arai H; Yang Y; Baca Y; Millstein J; Denda T; Ou FS; Innocenti F; Takeda H; Kubota Y; Doi A; Horie Y; Umemoto K; Izawa N; Wang J; Battaglin F; Jayachandran P; Algaze S; Soni S; Zhang W; Goldberg RM; Hall MJ; Scott AJ; Hwang JJ; Lou E; Weinberg BA; Marshall J; Goel S; Xiu J; Michael Korn W; Venook AP; Sunakawa Y; Lenz HJ
Eur J Cancer; 2024 Apr; 201():113914. PubMed ID: 38359495
[TBL] [Abstract] [Full Text] [Related]
9. A novel MTORC2-AKT-ROS axis triggers mitofission and mitophagy-associated execution of colorectal cancer cells upon drug-induced activation of mutant KRAS.
Iskandar K; Foo J; Liew AQX; Zhu H; Raman D; Hirpara JL; Leong YY; Babak MV; Kirsanova AA; Armand AS; Oury F; Bellot G; Pervaiz S
Autophagy; 2024 Jun; 20(6):1418-1441. PubMed ID: 38261660
[TBL] [Abstract] [Full Text] [Related]
10. Light-enhanced VEGF
Longva AS; Berg K; Weyergang A
Front Immunol; 2023; 14():1278000. PubMed ID: 38173721
[TBL] [Abstract] [Full Text] [Related]
11.
Jung EJ; Kim HJ; Shin SC; Kim GS; Jung JM; Hong SC; Kim CW; Lee WS
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139333
[TBL] [Abstract] [Full Text] [Related]
12. New ruthenium-xanthoxylin complex eliminates colorectal cancer stem cells by targeting the heat shock protein 90 chaperone.
Santos LS; Silva VR; de Castro MVL; Dias RB; Valverde LF; Rocha CAG; Soares MBP; Quadros CA; Dos Santos ER; Oliveira RMM; Carlos RM; Nogueira PCL; Bezerra DP
Cell Death Dis; 2023 Dec; 14(12):832. PubMed ID: 38102125
[TBL] [Abstract] [Full Text] [Related]
13. Machine learning based prediction of recurrence after curative resection for rectal cancer.
Jeon Y; Kim YJ; Jeon J; Nam KH; Hwang TS; Kim KG; Baek JH
PLoS One; 2023; 18(12):e0290141. PubMed ID: 38100485
[TBL] [Abstract] [Full Text] [Related]
14. Unveiling the role of hypoxic macrophage-derived exosomes in driving colorectal cancer progression.
Jiang J; Wang W; Zhu L; Shi B; Chen Y; Xia Y; Feng W; Yao W; Lu A; Zhang H
Front Immunol; 2023; 14():1260638. PubMed ID: 38022589
[TBL] [Abstract] [Full Text] [Related]
15. Inhibition of TRAP1 Accelerates the DNA Damage Response, Activation of the Heat Shock Response and Metabolic Reprogramming in Colon cancer Cells.
Bhasin N; Dabral P; Senavirathna L; Pan S; Chen R
Front Biosci (Landmark Ed); 2023 Sep; 28(9):227. PubMed ID: 37796715
[TBL] [Abstract] [Full Text] [Related]
16. High CD142 Level Marks Tumor-Promoting Fibroblasts with Targeting Potential in colorectal cancer.
Soós AÁ; Kelemen A; Orosz A; Szvicsek Z; Tölgyes T; Dede K; Bursics A; Wiener Z
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511344
[TBL] [Abstract] [Full Text] [Related]
17. An Overview of Recent Findings that Shed Light on the Connection between Fat and cancer.
Pandit P; Shirke C; Bhatia N; Godad A; Belemkar S; Patel J; Zine S
Endocr Metab Immune Disord Drug Targets; 2024; 24(2):178-193. PubMed ID: 37489790
[TBL] [Abstract] [Full Text] [Related]
18. [STIP1 correlates with tumor immune infiltration and prognosis as a potential immunotherapy target: a pan-cancer bioinformatics analysis].
Guan S; Shen Z; Lin M; Deng H; Fang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jul; 43(7):1179-1193. PubMed ID: 37488801
[TBL] [Abstract] [Full Text] [Related]
19. Deactivation of glycogen synthase kinase-3β by heat shock‑inducible tumor small protein attenuates hyperthermia‑induced pro‑migratory activity in colorectal cancer cells.
Koizumi K; Domoto T; Minamoto T; Satomura K; Nakajima H
Int J Oncol; 2023 Aug; 63(2):. PubMed ID: 37387443
[TBL] [Abstract] [Full Text] [Related]
20. Heat shock protein 90 C-terminal inhibitor PNSA promotes anticancer immunology of CD8
Zhang A; Li M; Wang Y; Xiong Y; Zhu T; Qi X; Li J
Int Immunopharmacol; 2023 Aug; 121():110471. PubMed ID: 37356120
[TBL] [Abstract] [Full Text] [Related]
[Next]
